Healthy returns: Pfizer execs chart out obesity strategy after encouraging drug data

Pfizer made one thing clear this week: It's officially back in the obesity race.
Best Life on MSN

6 Ways the New Wegovy Pill Compares to the Shot for Weight Loss

How does the new Wegovy pill compare to the shot for weight loss? Here are six ways, from side effects to absorption.
Medical Xpress

Once-weekly eloralintide leads to 20% weight loss in Phase II trial

A multicenter team including Endeavor Health and Eli Lilly found that once-weekly eloralintide produced dose-dependent weight loss up to 20% over 48 weeks in adults with obesity or overweight without ...
Hosted on MSN

New weekly jab targets long-lasting weight loss

Scientists have developed a new weekly weight loss jab, RES-010, which targets the RNA molecule miR-22, a key regulator of obesity-related processes. RES-010 aims to achieve long-lasting weight loss ...